跳转至内容
Merck

A0637

Sigma-Aldrich

DL-2-氨基己二酸

≥99% (TLC), powder, gliotoxic

别名:

DL-α氨基己二酸

登录查看公司和协议定价


About This Item

线性分子式:
HO2C(CH2)3CH(NH2)CO2H
CAS号:
分子量:
161.16
EC號碼:
MDL號碼:
分類程式碼代碼:
12352106
PubChem物質ID:
NACRES:
NA.32

product name

DL-2-氨基己二酸, ≥99%

化驗

≥99%

形狀

powder

mp

196-198 °C (lit.)

儲存溫度

2-8°C

SMILES 字串

NC(CCCC(O)=O)C(O)=O

InChI

1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)

InChI 密鑰

OYIFNHCXNCRBQI-UHFFFAOYSA-N

基因資訊

正在寻找类似产品? 访问 产品对比指南

應用

DL-2-氨基己二酸(AAA)已被用作一种astrotoxin 毒素,用于杀死可阻止移植的细胞有效整合到视网膜中的星形胶质细胞。它还被用作胶质毒素来研究星形胶质细胞膨胀对弯曲度的影响。

生化/生理作用

DL-2-氨基己二酸(AAA)是谷氨酸盐的六碳同系物和胶质毒性化合物。它通常用于显著减少小脑培养物中的星形胶质细胞数目,该培养物可用作研究a-氨基己二酸诱导的神经胶质毒性机制的模型。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Skin Sens. 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Q Wu et al.
European journal of pharmacology, 281(1), 55-61 (1995-07-25)
L-alpha-Aminoadipic acid is a lysine metabolite with neuroexcitatory properties, and has previously been shown to inhibit the production of the broad spectrum excitatory amino acid receptor antagonist kynurenic acid in brain tissue slices. The effects of L-alpha-aminoadipic acid on the
Huadong Ni et al.
Journal of neuroinflammation, 16(1), 1-1 (2019-01-05)
Despite accumulating evidence on the role of glial cells and their associated chemicals in mechanisms of pain, few studies have addressed the potential role of chemokines in the descending facilitation of chronic pain. We aimed to study the hypothesis that
Gliotoxin-induced swelling of astrocytes hinders diffusion in brain extracellular space via formation of dead-space microdomains
Sherpa AD, et al.
Glia, 62(7), 1053-1065 (2014)
Gliotoxic effects of $\alpha$-aminoadipic acid on monolayer cultures of dissociated postnatal mouse cerebellum
Huck S, et al.
Neuroscience, 12(3), 783-791 (1984)
Saadet Mercimek-Mahmutoglu et al.
Pediatrics, 129(5), e1368-e1372 (2012-04-25)
Pyridoxine-dependent epilepsy (PDE) was first described in 1954. The ALDH7A1 gene mutations resulting in α-aminoadipic semialdehyde dehydrogenase deficiency as a cause of PDE was identified only in 2005. Neonatal epileptic encephalopathy is the presenting feature in >50% of patients with

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门